Track topics on Twitter Track topics that are important to you
SAN FRANCISCO, July 31, 2017 /PRNewswire/ --
The global breast lesion localization methods market is expected to reach USD 1.57 billion by 2025, according to a new report by Grand View Research, Inc. The increasing government and non-government reimbursement policies for mammary gland cancer diagnosis, biopsy, pre-surgical examinations, and other treatment options is estimated to increase the adoption of breast lesion localization procedures. For instance, the Alabama Breast and Cervical Cancer Early Detection Program aims to provide breast and cervical oncology diagnostic and screening services to women who meet certain income, age, and insurance coverage eligibility guidelines.
Furthermore, rising prevalence of breast cancer is anticipated to propel the market growth. The disease is highly prevalent amongst women belonging to the age group of 65 years or above. The maximum risk of mammary gland cancer is between the age of 70 and 79. On the other hand, men are also at a risk of breast cancer. In the U.S., median age of men at diagnosis is approximately 68 years.
Browse full research report with TOC on "Breast Lesion Localization Methods Market Size & Forecast By Type (Wire Localization Biopsy, Radioisotope Localization, Radio-Guided Occult-lesion Localization (ROLL), Radioactive Seed Localization (RSL), Magnetic Tracer), And Trend Analysis, 2014 - 2025" at: http://www.grandviewresearch.com/industry-analysis/breast-lesion-localization-methods-market
Further key findings from the report suggest:
Browse related reports by Grand View Research:
Grand View Research has segmented the global breast lesion localization methods market on the basis of type and region:
Read Our Blog: http://www.grandviewresearch.com/blogs/healthcare
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Corporate Sales Specialist, USA
Grand View Research, Inc
Toll Free: +1-888-202-9519
SOURCE Grand View Research, Inc.NEXT ARTICLE
Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...